ガイドライン

(旧版)エビデンスに基づいた胆道癌診療ガイドライン[第1版]

書誌情報
II:胆道癌診療アルゴリズム

 
引用文献

1) Tashiro S, Imaizumi T, Ohkawa H, Okada A, Katoh T, Kawarada Y, et al. Pancreaticobiliary maljunction: retrospective and nationwide survey in Japan. J Hepatobiliary Pancreat Surg. 2003;10:345-51.
2) Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ Jr, Larusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg. 1991;213:21-5.
3) Rosen CB, Nagorney DM. Cholangiocarcinoma complicating primary sclerosing cholangitis. Semin Liver Dis. 1991;11:26-30.
4) Callea F, Sergi C, Fabbretti G, Brisigotti M, Cozzutto C, Medicina D. Precancerous lesions of the biliary tree. J Surg Oncol Suppl. 1993;3:131-3.
5) Franco J, Saeian K. Biliary tract inflammatory disorders. primary sclerosing cholangitis and primary biliary cirrhosis. Curr Gastroenterol Rep. 1999;1:95-101.
6) Thuluvath PJ, Rai R, Venbrux AC, Yeo CJ. Cholangiocarcinoma: a review. Gastroenterologist. 1997;5:306-15.
7) Yeo CJ, Pitt HA, Cameron JL. Cholangiocarcinoma. Surg Clin N Am. 1990;70:1429-47.
8) Sugiyama M, Atomi Y, Kuroda A, Muto T. Bile duct carcinoma without jaundice: clues to early diagnosis. Hepatogastroenterology. 1997;44:1477-83.
9) Malik IA. Clinicopathological features and management of gallbladder cancer in Pakistan: A prospective study of 233 cases. J Gastroenterol Hepatol. 2003;18:950-3.
10) Al-Quadah MS, Daradkeh S, Sroujieh AS, Farah GR, Masaad J. Gallbladder carcinoma in Jordan. Hepatogastroenterology 2005;61:5-7.
11) Nieveen Van Dijkum EJ, Terwee CB, Oosterveld P, Van Der Meulen JH, Gouma DJ, De Haes JC. Validation of the gastrointestinal quality of life index for patients with potentially operable periampullary carcinoma. Br J Surg. 2000;87:110-5.
12) Kamisawa T, Tu Y, Egawa N, Nakajima H, Horiguchi S, Tsuruta K, et al. Clinicopathologic features of ampullary carcinoma without jaundice. J Clin Gastroenterol. 2006;40:162-6.
13) de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med. 1999;341:1368-79.
14) Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet. 2005;366:1303-14.
15) Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol. 2003;4:167-76.
16) Piantino P, Fusaro A, Randone A, Cerchier A, Daziano E. Increased levels of CA19-9, CA50 and CA125 in patients with benign disease of biliary tract and the pancreas. J Nucl Med Allied Sci. 1990;34:97.
17) Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ. The utility of CA19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol. 2000;95:204-207.
18) Nichols JC, Gores GJ, LaRusso NF, Wiesner RH, Nagorney DM, Ritts RE Jr. Diagnostic role of serum CA19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc. 1993;68:874-9.
19) Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenbera WM, Taylor-Robinson SD, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma:consensus document. Gut. 2002;51:1-9.
20) Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Pentillä I, Alhava E. Clinical value of serum tumor marker CEA, CA50 and CA242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis;results from a prospective study. Anticancer Res. 1992;12:1687-93.
21) Han JK, Choi BI, Kim AY, An SK, Lee JW, Kim TK, et al. Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings. Radiographics. 2002;22:173-87.
22) Khan SA, Davidson BR, Goldin R, Pereria SP, Rosenbera WM, Taylor-Robinson SD, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002;51:1-9.
23) Chen HW, Pan AZ, Zhen ZJ, Su SY, Wang JH, Yu SC, et al. Preoperative evaluation of resectability of Klatskin tumor with 16-MDCT angiography and cholangiography. Am J Roentgenol. 2006;186:1580-6.
24) Lopera JE, Soto JA, Munera F. Malignant hilar and perihilar biliary obstruction: use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions. Radiology. 2001;220:90-6.
25) Romagnuolo J, Bardou M, Rahme E, Joseph L, Reinhold C, Barkun AN. Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease. Ann Intern Med. 2003;139:547-57.
26) Barish MA, Yocel EK, Ferrucci JT. Magnetic resonance cholangiopancreatography. N Engl J Med. 1999;341:258-64.
27) Park MS, Kim TK, Kim KW, Perk SW, Lee JK, Kim JS, et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology. 2004;233:234-40.
28) Sakamoto E, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Nagino M, et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg. 1998;227:405-11.
29) Hayashi S, Miyazaki M, Kondo Y, Nakajima N. Invasive growth patterns of hepatic hilar ductal carcinoma. A histologic analysis of 18 surgical cases. Cancer. 1994;73:2922-9.
30) Nimura Y, Kamiya J, Hayakawa N, Shionoya S. Cholangioscopic differentiation of biliary strictures and polyps. Endoscopy. 1989;21 Suppl 1:351-6.
31) Nimura Y. Staging of biliary carcinoma: cholangiography and cholangioscopy. Endoscopy. 1993;25:76-80.
32) 高田忠敬,小林誠一郎,山田明義,鈴木茂,内村逸郎,中村光司,他.閉塞性黄疸に対する経皮的肝内胆管ドレナージによる黄疸軽減法について―経皮的胆道鏡検査法にもふれて―.東女医大誌.1972;42:692-700.
33) Takada T, Hanyu F, Kobayashi S, Mikoshiba Y, Hamano K. Percutaneous transhepatic cholangiodrainage and cholangioscopy for the case of severe obstructive jaundice caused by pancreatic tumor. In: Stefanini P, Speranza V, editors. Proceedings of the 18th World Congress of the Int Coll Surg. New York: Excerpta Medica Amsterdam American Elsevier company, 1973:478-81.
34) Itoi T, Sofuni A, Itokawa F, Tsuchiya T, Kurihara T, Ishii K, et al. Peroral cholangioscopic diagnosis of biliary-tract diseases by using narrow-band imaging (with videos). Gastrointest Endosc. 2007;66:730-36.
35) Fukuda Y, Tsuyuguchi T, Sakai Y, Tsuchiya S, Saisyo H. Diagnostic utility of peroral cholangioscopy for various bile-duct lesions. Gastrointest Endosc. 2005;62:374-82.
36) Sugiyama M, Atomi Y, Yamato T. Endoscopic ultrasonography for differential diagnosis of polypoid gall bladder lesions: analysis in surgical and follow up series. Gut. 2000;46:250-4.
37) Azuma T, Yoshikawa T, Araida T, Takasaki K. Differential diagnosis of polypoid lesion of the gallbladder by endoscopic ultrasonography. Am J Surg. 2001;181:65-70.
38) Hirooka Y, Naitoh Y, Goto H, Ito A, Hayakawa S,Watanabe Y, et al. Contrast-enhanced endoscopic ultrasonography in gallbladder diseases. Gastrointest Endosc. 1998;48:406-10.
39) Furukawa H, Kosuge T, Shimada K, Yamamoto J, Kanai Y, Mukai K, et al. Small polypoid lesions of the gallbladder. Arch Surg. 1998;133:735-9.
40) Kumaran V, Gulati S, Paul B, Pande K, Sahni P, Chattopadhyay K. The role of dual-phase helical CT in assessing resectability of carcinoma of the gallbladder. Eur Radiol. 2002;12:1993-9.
41) Kim JH, Kim TK, Eun HW. Preoperative evaluation of gallbladder carcinoma: efficacy of combined use of MR imaging, MR cholangiography, and contrast-enhanced dual phase three dimensional MR angiography. J Magn Reson Imaging. 2002;16:676-84.
42) Schwartz LH, Black J, Fong Y, Jarnagin W, Blumgart L, Gruen D, et al. Gallbladder carcinoma:findings at MR imaging with MR cholangiopancreatography. Comput Assist Tomogr. 2002;26:405-10.
43) Menzel J, Hoepffner N, Sulkowski U, Reimer P, Heinecke A, Poremba C, et al. Polypoid tumors of the major duodenal papilla: preoperative staging with intraductal US, EUS, and CT--a prospective, histopathologically controlled study. Gastrointest Endosc. 1999;49:349-57.
44) Itoh A, Goto H, Naitoh Y, Hirooka Y, Furukawa T, Hayakawa T. Intraductal ultrasonography in diagnosing tumor extension of cancer of the papilla of Vater. Gastrointest Endoscopy. 1997;45:251-60.
45) Weber SM, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Ann Surg. 2002;235:392-9.
46) Kondo S, Nimura Y, Hayakawa N, Kamiya J, Nagino M, Uesaka K. Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma. Br J Surg. 2000;87:418-22.
47) Shimada H, Endo I, Togo S, Nakano A, Izumi T, Nakagawara G. The role of lymph node dissection in the treatment of gallbladder carcinoma. Cancer. 1997;79:892-9.
48) Nishio H, Nagino M, Ebata T, Yokoyama Y, Igami T, Nimura Y. Aggressive surgery for stage IV gallbladder carcinoma; what are the contraindications? J Hepatobiliary Pancreat Surg. 2007;14:351-7.
49) Kitagawa Y, Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg. 2001;233:385-92.
50) Poveski SP, Karpeh MS Jr, Conlon KC, Blumgart LH, Brennan MF. Association of preoperative biliary drainage with postoperative outcome following pancreatoduodenestomy. Ann Surg. 1999;230:131-42.
51) Sewnath ME, Birjmohum RS, Rauws EA, Heiberegtes K, Obertop H, Gouma DJ. The effect of preoperative biliary drainage on postoperative complications after pancreatoduodenectomy. J Am Coll Surg. 2001;192:726-34.
52) Martignoni ME, Wabner M, Krähhenbühl L, Redaelli CA, Friess H, Bücher MW. Effect of preoperative biliary drainage on surgical outcome after pancreatoduodenectomy. Am J Surg. 2001;181:52-9.
53) Pisters PW, Hudec WA, Hess KR, Lee JE, Vauthey JN, Lahoti S, et al. Effect of preoperative biliary decompression on pancreatoduodenectomy-Associated morbidity in 300 consective patients. Ann Surg. 2001;234:47-55.
54) Takada T. Is preoperative biliary drainage necessary according to evidence-based medicine? J Hepatobiliary Pancreato Surg 2001;8:58-64.
55) Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, Hayakawa K, et al. Complications of Hilar holangiocarcinoma. World J Surg. 2001;25:1277-83.
56) Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V, et al. Portal vein embolization before right hepatectomy:prospective clinical trial. Ann Surg. 2003;237:208-17.
57) Hemming AW, Reed AI, Fujita S, Foley DP, Howard RJ. Surgical management of hilar cholangiocarcinoma. Ann Surg 2005;241:693-9.
58) Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg. 2003;238:73-83.
59) Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg. 2003;238:84-92.
60) Kondo S, Hirano S, Ambo Y, Tanaka E, Okushiba S, Morikawa T, et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins:results of a prospective study. Ann Surg. 2004;240:95-101.
61) NaginoM, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243:364-72.
62) Sano T, Shimada K, Sakamoto Y, Yamamoto J, Yamasaki S, Kosuge T. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg. 2006;244:240-7.
63) Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg. 1990;14:535-43.
64) Gazzaniga GM, Filauro M, Bagarolo C, Mori L. Surgery for hilar cholangiocarcinoma: Italian experience, J. Hepatobiliary Pancreat Surg. 2000;7:122-7.
65) Lee SG, Lee YJ, P ark KM, Hwang S, Min PC. One hundred and eleven liver resections for hilar bile duct cancer, J. Hepatobiliary Pancreat Surg 2000;7:135-41.
66) Su CH, Tsay SH, Wu CC, Shyr YM, King KL, Lee CH, et al. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg. 1996;223:384-94.
67) Kayahara M, Nagakawa T, Ohta T, Kitagawa H, Tajima H, Miwa K. Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer. Ann Surg. 1999;229:76-83.
68) Ebata T, Watanabe H, Ajioka Y, Oda K, Nimura Y. Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg. 2002;89:1260-7.
69) Jang JY, Kim SW, Park DJ, Ahn YJ, Yoon YS, Choi MG, et al. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg. 2005;241:77-84.
70) Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y. Hepatectomy with portal vein resection for hilar cholangiocarcinoma:audit of 52 consecutive cases. Ann Surg. 2003;238:720-7.
71) Miyazaki M, Kato A, Ito H, Kimura F, Shimizu H, Ohtsuka M, et al. Combained vascular resection in operative resection for hilar cholangiocarcinoma:dose it work or not. Surgery 2007;141:581-8.
72) Suzuki T, Yoshidome H, Kimura F, Shimizu H, Ohtsuka M, Kato A, et al. Renal function is well maintained after use of left renal vein graft for vascular reconstruction in hepatobiliary-pancreatic surgery. J Am Coll Surg. 2006;202:87-92.
73) Nimura Y, Hayakawa N, Kamiya J, Maeda S, Kondo S, Yasui A, et al. Combined portal vein and liver resection for carcinoma of the biliary tract. Br J Surg. 1991;78:727-31.
74) Hemming AW, Kim RD, Mekeel KL, Fujita S, Reed AI, Foley DP, et al. Portal vein resection for hilar cholangiocarcinoma. Am Surg. 2006;72:599-604;discussion 604-605.
75) Kondo S, Nimura Y, Hayakawa N, Kamiya J, Nagino M, Uesaka K. Extensive surgery for carcinoma of the gallbladder. Br J Surg. 2002;89:179-84.
76) Miyazaki M, Itoh H, Ambiru S, Shimizu H, Togawa A, Gohchi E, et al. Radical surgery for advanced gallbladder carcinoma. Br J Surg. 1996;83:478-81.
77) Klein P, Reingruber B, Kastl S, Dworak O, Hohenberger W. Is local excision of pT1-ampullary carcinomas justified? Eur J Surg Oncol. 1996;22:366-71.
78) Paramythiotis D, Kleeff J, Wirtz M, Friess H, Büchler MW. Still any transduodenal local excision in tumors of the papilla of Vater? J Hepatobiliary Pancreat Surg. 2004;11:239-44.
79) Beger HG, Treitschke F, Gansauge F, Harada N, Hiki N, Mattfeldt T. Tumor of the Ampulla of Vater. Arch Surg. 1999;134:526-32.
80) Todoroki T, Iwasaki Y, Orii K, Otsuka M, Ohara K, Kawamoto T, et al. Resection combined with intraoperative radiation therapy (IORT) for stage IV (TNM) gallbladder carcinoma. World J Surg. 1991;15:357-66.
81) Todoroki T, Kawamoto T, Otsuka M, Koike N, Yoshida S, Takada Y, et al. Benefits of combining radiotherapy with aggressive resection for stage IV gallbladder cancer. Hepatogastroenterology. 1999;46:1585-91.
82) González D, Gerard JP, Maners AW, De la Lande-Guyaux B, Van Dijk-Milatz A, et al. Results of radiation therapy in carcinoma of the proximal bile duct (Klatskin tumor). Semin Liver Dis. 1990;10:131-41.
83) Langer JC, Langer B, Taylor BR, Zeldin R, Cummings B. Carcinoma of the extrahepatic bile ducts: results of an aggressive surgical approach. Surgery. 1985;98:752-9.
84) Stein DE, Heron DE, Rosato EL, Anne PR, Topham AK. Positive microscopic margins alter outcome in lymph nodenegative cholangiocarcinoma when resection is combined with adjuvant radiotherapy. Am J Clin Oncol. 2005;28:21-3.
85) Speer AG, Cotton PB, Russell RC, Mason RR, Hatfield AR, Leung JW, et al. Randamised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet. 1987;2:57-62.
86) Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet. 1994;344:1655-60.
87) Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet. 1992;340:1488-92.
88) Kaassis M, Boyer J, Dumas R, Ponchon T, Coumaros D, Delcenserie R, et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc. 2003;57:178-82.
89) Levy MJ, Baron TH, Gostout CJ, Petersen BT, Farnell MB. Palliation of malignant extrahepatic biliary obstruction with plastic versus expandable metal stents: An evidence-based approach. Clin Gastroenterol Hepatol. 2004;2:273-85.
90) Hausegger KA, Thurnher S, Bodendörfer G, Zollikofer CL, Uggowitzer M, Kugler C, et al. Treatment of malignant biliary obstruction with polyurethane-covered Wallstents. Am J Roengenol. 1998;170:403-8.
91) Isayama H, Komatsu Y, Tsujino T, Sasahira N, Hirano K, Toda N, et al. Aprospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction. Gut. 2004;53:729-34.
92) Wagner HJ, Knyrim K, Vakil N, Klose KJ. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. A prospective and randomized trial. Endoscopy. 1993;25:213-6.
93) Glimelius B, Hoffman K, Sjödén PO, Jacobsson G, Sellström H, Enander LK, et al. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol. 1996;7:593-600.
94) Takada T, Nimura Y, Katoh H, Nagakawa T, Nakayama T, Matsushiro T, et al. Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial. Hepatogastroenterology. 1998;45:2020-6.
95) Okusaka T, Ishii H, Funakoshi A, Yamao K, Ohkawa S, Saito S, et al. Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol. 2006;57:647-53.
96) Ishii H, Furuse J, Yonemoto N, Nagase M, Yoshino M, Sato T. Chemotherapy in the treatment of advanced gallbladder cancer. Oncology. 2004;66:138-42.
97) Grove MK, Hermann RE, Vogt DP, Broughan TA. Role of radiation after operative palliation in cancer of the proximal bile ducts. Am J Surg. 1991;161:454-8.
98) Tollenaar RA, van de Velde CJ, Taat CW, Gonzalez D, Leer JW, Hermans J. External radiotherapy and extrahepatic bile duct cancer. Eur J Surg. 1991;157:587-9.
99) Hejna M, Pruckmayer M, Raderer M. The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer. 1998;34:977-86.
100) Ortner ME, Caca K, Berr F, Liebetruth J, Mansmann U, Huster D, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: A randomized prospective study. Gastroenterology. 2003;125:1355-63.
101) Zoepf T, Jakobs R, Arnold JC, Apel D, Riemann JF. Palliation of nonresectable bile duct cancer: Improved survival after photodynamic therapy. Am J Gastroenterol. 2005;100:2426-30.

 

書誌情報